- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
DRW3
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Drägerwerk AG & Co. KGaA · Healthcare · Medical Devices
Latest close
109.8 EUR
0.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 23.5% above the Trend Line and sits at 92.8% of its 52-week range. The latest completed week returned 0.5%, after a 32.0% four-week move. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high.
Setup score
62
out of 100
Latest Close
109.8 EUR
7 Aug 2026
1W Return
0.5%
latest completed week
4W Return
32.0%
short-term follow-through
12W Return
35.6%
quarterly tape
Trend Breadth
92.3%
48 of 52 weeks active
Volume Ratio
-
vs 13-week average
- 5 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
0.5%
Latest completed week; four-week move 32.0%.
Indicator stack
65/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
52/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 23.5% above the Trend Line and sits at 92.8% of its 52-week range. The latest completed week returned 0.5%, after a 32.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6512-week average 0.69
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers
No recent accumulation markers. 5 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 32.0% over four weeks, 35.6% over 12 weeks, and 67.4% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year48
Trend breadth92.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.53Latest activity-pressure read.
Pressure change154.9%Four-week change in activity pressure.
Leadership13.59Latest relative-leadership reading.
RS change220.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 4 relevant articles.
1 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.3%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+13.5%Week of 22 May.
Worst week-8.0%Week of 15 May.
Latest week+0.5%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains5
Flat weeks1
Modest losses9
Sharp losses4
Recent vol6.5%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split26/22Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank1 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Devices
4-week rank1 / 15
Group average6.7%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD86.7%positive activity pressure
RS13.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis48/100Latest 12-week confirmation: trend 11/12, activity pressure 2/12, relative leadership 6/12.
Activity pressure 0.65; 5 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 4 relevant articles.
Is Drägerwerk KGaA (XTRA:DRW3) Undervalued As Q2 Earnings Lift Sales And Net Income? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 109.8 EUR | 0.5% | 88.92 EUR | 59.13 EUR | 0.53 | 13.59 | 0 | On |
| 31 Jul 2026 | 109.2 EUR | 12.9% | 87.70 EUR | 58.69 EUR | 0.03 | 16.78 | 66 | On |
| 24 Jul 2026 | 96.70 EUR | 9.9% | 86.28 EUR | 58.26 EUR | -0.48 | 3.72 | 133 | On |
| 17 Jul 2026 | 88.00 EUR | 5.8% | 85.28 EUR | 57.90 EUR | -0.83 | -4.22 | 363 | On |
| 10 Jul 2026 | 83.20 EUR | -3.0% | 84.53 EUR | 57.60 EUR | -0.96 | -11.28 | 111 | Off |
| 3 Jul 2026 | 85.80 EUR | 2.3% | 83.97 EUR | 57.34 EUR | -0.91 | -9.89 | 0 | On |
| 26 Jun 2026 | 83.90 EUR | 0.0% | 83.32 EUR | 57.04 EUR | -0.75 | -9.86 | 0 | On |
| 19 Jun 2026 | 83.90 EUR | -4.1% | 82.80 EUR | 56.76 EUR | -0.60 | -11.73 | 0 | On |
| 12 Jun 2026 | 87.50 EUR | -4.0% | 82.23 EUR | 56.48 EUR | -0.44 | -4.29 | 0 | On |
| 5 Jun 2026 | 91.10 EUR | -0.2% | 81.53 EUR | 56.19 EUR | -0.54 | 2.30 | 0 | On |
| 29 May 2026 | 91.30 EUR | -0.7% | 80.69 EUR | 55.86 EUR | -0.59 | 1.35 | 0 | On |
| 22 May 2026 | 91.90 EUR | 13.5% | 80.02 EUR | 55.53 EUR | -0.63 | 4.86 | 0 | On |
| 15 May 2026 | 81.00 EUR | -8.0% | 79.46 EUR | 55.21 EUR | -0.63 | -5.52 | 0 | On |
| 8 May 2026 | 88.03 EUR | 0.8% | 79.21 EUR | 54.96 EUR | -0.22 | 2.25 | 19 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.